Eric Miller

Senior Director and Scientific Project Leader of Analytical

Dr. Eric Miller has been in the biopharmaceutical industry since 1996, where he received an initial exposure to antibodies and associated technologies while developing lateral flow diagnostics for the Quidel corporation. Eric has been with Abzena for over 4 years.

In his initial role with the organization Eric served as the Senior Director of the San Diego AMDQC department and later moved to a global position within Abzena’s Scientific Leadership team wherein he serves as analytical subject matter expert.

Prior to joining Abzena, he spent an extensive stint in academia, conducting his PhD studies at Scripps Institution of Oceanography under Professor William Fenical and went on to do postdoctoral research at the California Institute of Technology under Professor Raymond Deshaies and at the Scripps Research Institute under Professor Peter G. Schultz.

Since completing his academic training Eric has provided analytical support for multiple phases of drug development in arenas ranging from early R&D to Commercial.

Eric is one of Abzena’s Senior Analytical Leaders, and is a key member of our team who developed LabZient™, our cutting-edge analytical platform. Eric can offer valuable insights into how this platform is streamlining and de-risking the pathway to Investigational New Drug (IND) applications and beyond for our customers.

Contact Our Expert

What is your biologic drug development challenge? Ask our expert today. We are ready to help.